Engineered nanocarriers enhance molecular sonosensitizer delivery within cells, suggesting improved therapeutic performance.
Therapeutic performance of drugs is often limited by the inefficient targeting/delivery to intracellular targets. This study presents engineered polymeric nanomicelle-based nuclear delivery of molecular sonosensitizers with enhanced therapeutic performance under...
No takes yet. Share an insight, caveat, or question.
Shaw et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: